170 related articles for article (PubMed ID: 19826414)
21. p53-responsive miR-194 inhibits thrombospondin-1 and promotes angiogenesis in colon cancers.
Sundaram P; Hultine S; Smith LM; Dews M; Fox JL; Biyashev D; Schelter JM; Huang Q; Cleary MA; Volpert OV; Thomas-Tikhonenko A
Cancer Res; 2011 Dec; 71(24):7490-501. PubMed ID: 22028325
[TBL] [Abstract][Full Text] [Related]
22. Sustained regression of tumors upon MYC inactivation requires p53 or thrombospondin-1 to reverse the angiogenic switch.
Giuriato S; Ryeom S; Fan AC; Bachireddy P; Lynch RC; Rioth MJ; van Riggelen J; Kopelman AM; Passegué E; Tang F; Folkman J; Felsher DW
Proc Natl Acad Sci U S A; 2006 Oct; 103(44):16266-71. PubMed ID: 17056717
[TBL] [Abstract][Full Text] [Related]
23. Development of a reactive stroma associated with prostatic intraepithelial neoplasia in EAF2 deficient mice.
Pascal LE; Ai J; Masoodi KZ; Wang Y; Wang D; Eisermann K; Rigatti LH; O'Malley KJ; Ma HM; Wang X; Dar JA; Parwani AV; Simons BW; Ittman MM; Li L; Davies BJ; Wang Z
PLoS One; 2013; 8(11):e79542. PubMed ID: 24260246
[TBL] [Abstract][Full Text] [Related]
24. Roles of thrombospondin-1 and -2 in regulating corneal and iris angiogenesis.
Cursiefen C; Masli S; Ng TF; Dana MR; Bornstein P; Lawler J; Streilein JW
Invest Ophthalmol Vis Sci; 2004 Apr; 45(4):1117-24. PubMed ID: 15037577
[TBL] [Abstract][Full Text] [Related]
25. Induction of activating transcription factor 1 by nickel and its role as a negative regulator of thrombospondin I gene expression.
Salnikow K; Wang S; Costa M
Cancer Res; 1997 Nov; 57(22):5060-6. PubMed ID: 9371503
[TBL] [Abstract][Full Text] [Related]
26. Cell-type specific regulation of thrombospondin-1 expression and its promoter activity by regulatory agents.
Kim SA; Kang JH; Cho I; Bae SW; Hong KJ
Exp Mol Med; 2001 Sep; 33(3):117-23. PubMed ID: 11642546
[TBL] [Abstract][Full Text] [Related]
27. EAF2 regulates DNA repair through Ku70/Ku80 in the prostate.
Ai J; Pascal LE; Wei L; Zang Y; Zhou Y; Yu X; Gong Y; Nakajima S; Nelson JB; Levine AS; Lan L; Wang Z
Oncogene; 2017 Apr; 36(15):2054-2065. PubMed ID: 27721405
[TBL] [Abstract][Full Text] [Related]
28. Expression of thrombospondin-1 is correlated with microvessel density in gastric carcinoma.
Zhang J; Ito R; Oue N; Zhu X; Kitadai Y; Yoshida K; Nakayama H; Yasui W
Virchows Arch; 2003 Jun; 442(6):563-8. PubMed ID: 12719977
[TBL] [Abstract][Full Text] [Related]
29. Thrombospondin-1, vascular endothelial growth factor expression and their relationship with p53 status in prostate cancer and benign prostatic hyperplasia.
Kwak C; Jin RJ; Lee C; Park MS; Lee SE
BJU Int; 2002 Feb; 89(3):303-9. PubMed ID: 11856116
[TBL] [Abstract][Full Text] [Related]
30. Dysregulated ΔNp63α negatively regulates the maspin promoter in keratinocytes via blocking endogenous p73 binding.
King KE; Reddi DM; Ponnamperuma RM; Gerdes M; Weinberg WC
Mol Carcinog; 2014 Sep; 53(9):698-710. PubMed ID: 23475637
[TBL] [Abstract][Full Text] [Related]
31. The novel tumor suppressor NOL7 post-transcriptionally regulates thrombospondin-1 expression.
Doçi CL; Zhou G; Lingen MW
Oncogene; 2013 Sep; 32(37):4377-86. PubMed ID: 23085760
[TBL] [Abstract][Full Text] [Related]
32. Dynamic intracellular distribution of Eaf2 and its potential involvement in UV-Induced DNA damage response.
Zhuang F; Yen P; Zhao J; Nguyen M; Jiang M; Liu YH
DNA Cell Biol; 2008 Dec; 27(12):649-56. PubMed ID: 18803460
[TBL] [Abstract][Full Text] [Related]
33. The role of hypoxia and p53 in the regulation of angiogenesis in bladder cancer.
Reiher FK; Ivanovich M; Huang H; Smith ND; Bouck NP; Campbell SC
J Urol; 2001 Jun; 165(6 Pt 1):2075-81. PubMed ID: 11371931
[TBL] [Abstract][Full Text] [Related]
34. Identification of Daxx interacting with p73, one of the p53 family, and its regulation of p53 activity by competitive interaction with PML.
Kim EJ; Park JS; Um SJ
Nucleic Acids Res; 2003 Sep; 31(18):5356-67. PubMed ID: 12954772
[TBL] [Abstract][Full Text] [Related]
35. Zebrafish eaf1 and eaf2/u19 mediate effective convergence and extension movements through the maintenance of wnt11 and wnt5 expression.
Liu JX; Hu B; Wang Y; Gui JF; Xiao W
J Biol Chem; 2009 Jun; 284(24):16679-16692. PubMed ID: 19380582
[TBL] [Abstract][Full Text] [Related]
36. Regulation of transcription of the human presenilin-1 gene by ets transcription factors and the p53 protooncogene.
Pastorcic M; Das HK
J Biol Chem; 2000 Nov; 275(45):34938-45. PubMed ID: 10942770
[TBL] [Abstract][Full Text] [Related]
37. Thrombospondin-1 is a transcriptional repression target of PRMT6.
Michaud-Levesque J; Richard S
J Biol Chem; 2009 Aug; 284(32):21338-46. PubMed ID: 19509293
[TBL] [Abstract][Full Text] [Related]
38. Leptin augments recruitment of IRF-1 and CREB to thrombospondin-1 gene promoter in vascular smooth muscle cells in vitro.
Sahu S; Ganguly R; Raman P
Am J Physiol Cell Physiol; 2016 Aug; 311(2):C212-24. PubMed ID: 27281481
[TBL] [Abstract][Full Text] [Related]
39. The application of an anti-angiogenic gene (thrombospondin-1) in the treatment of human prostate cancer xenografts.
Jin RJ; Kwak C; Lee SG; Lee CH; Soo CG; Park MS; Lee E; Lee SE
Cancer Gene Ther; 2000 Dec; 7(12):1537-42. PubMed ID: 11228532
[TBL] [Abstract][Full Text] [Related]
40. Activating transcription factor-1-mediated hepatocyte growth factor-induced down-regulation of thrombospondin-1 expression leads to thyroid cancer cell invasion.
Ghoneim C; Soula-Rothhut M; Blanchevoye C; Martiny L; Antonicelli F; Rothhut B
J Biol Chem; 2007 May; 282(21):15490-7. PubMed ID: 17409099
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
